XM5ZL1ICD-11 MMS 2026-01
Interleukin inhibitors
Index terms
- Interleukin inhibitors
Child codes
XM0NF8– SecukinumabXM1BA7– UstekinumabXM2FV1– TocilizumabXM2L20– GuselkumabXM3CD8– DaclizumabXM3CP6– AnakinraXM45G5– SarilumabXM4YD0– RilonaceptXM5JM2– BriakinumabXM6601– BrodalumabXM67R0– CanakinumabXM6FT1– BasiliximabXM70N9– RisankizumabXM7AB4– IxekizumabXM7N41– SirukumabXM9D29– SiltuximabXM9VJ6– Tildrakizumab
Sibling codes
XM0LG0– DarvadstrocelXM1079– Immunosuppressive drugXM2EM8– Dimethyl fumarateXM3CM4– Calcineurin inhibitorsXM5140– Selective immunosuppressantsXM5Q10– LenalidomideXM6B78– ThalidomideXM6S50– PomalidomideXM7952– PirfenidoneXM8X05– MepolizumabXM99R8– AzathioprineXM9PG4– Tumour necrosis factor alpha inhibitorsXM9UK4– Diroximel fumarate
Foundation entity
Interleukin inhibitors – http://id.who.int/icd/entity/1530497621
Part of: XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes